Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$76.01 - $86.7 $5,472 - $6,242
-72 Reduced 2.42%
2,909 $224,000
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $5,643 - $6,429
73 Added 2.51%
2,981 $247,000
Q4 2022

Jan 26, 2023

BUY
$62.32 - $89.47 $181,226 - $260,178
2,908 New
2,908 $0
Q4 2021

Feb 02, 2022

SELL
$64.88 - $73.64 $275,804 - $313,043
-4,251 Closed
0 $0
Q3 2021

Nov 01, 2021

SELL
$67.69 - $73.03 $418,053 - $451,033
-6,176 Reduced 95.43%
296 $296,000
Q3 2021

Nov 01, 2021

BUY
$67.69 - $73.03 $267,713 - $288,833
3,955 Added 1336.15%
4,251 $296,000
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $79,591 - $86,964
-1,254 Reduced 16.23%
6,472 $445,000
Q1 2021

May 06, 2021

BUY
$60.0 - $68.46 $360 - $410
6 Added 0.08%
7,726 $499,000
Q4 2020

Feb 02, 2021

BUY
$56.65 - $64.55 $437,338 - $498,326
7,720 New
7,720 $449,000
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $254,113 - $319,503
-4,092 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$72.34 - $84.0 $40,872 - $47,460
-565 Reduced 12.13%
4,092 $314,000
Q1 2020

May 01, 2020

BUY
$62.63 - $80.22 $17,599 - $22,541
281 Added 6.42%
4,657 $348,000
Q4 2019

Feb 03, 2020

SELL
$61.62 - $67.78 $11,707 - $12,878
-190 Reduced 4.16%
4,376 $284,000
Q3 2019

Nov 01, 2019

SELL
$62.51 - $69.0 $324,676 - $358,386
-5,194 Reduced 53.22%
4,566 $289,000
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $20,478 - $22,964
331 Added 3.51%
9,760 $659,000
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $17,133 - $19,193
274 Added 2.99%
9,429 $613,000
Q4 2018

Feb 11, 2019

SELL
$60.54 - $79.0 $302,942 - $395,316
-5,004 Reduced 35.34%
9,155 $572,000
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $57,736 - $63,925
-810 Reduced 5.41%
14,159 $1.09 Million
Q2 2018

Aug 07, 2018

SELL
$64.88 - $75.68 $146,693 - $171,112
-2,261 Reduced 13.12%
14,969 $1.06 Million
Q1 2018

Apr 18, 2018

SELL
$72.84 - $88.8 $311,318 - $379,531
-4,274 Reduced 19.88%
17,230 $1.3 Million
Q4 2017

Feb 07, 2018

SELL
$71.15 - $83.52 $390,969 - $458,942
-5,495 Reduced 20.35%
21,504 $1.54 Million
Q3 2017

Nov 08, 2017

SELL
$72.11 - $85.47 $69,514 - $82,393
-964 Reduced 3.45%
26,999 $2.19 Million
Q2 2017

Aug 08, 2017

BUY
N/A
27,963
27,963 $1.98 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.